Profluent
BiotechnologyWebsite
Developer of artificial intelligence-driven models designed to create and validate novel proteins for biomedicine. The company's platform leverages deep generative models trained on billions of biolog...
Valuation
$525M
Market implied
Share Price
N/A
Total Raised
$150M
Last Round
Early Stage VC (Series B)
Nov 2025
Latest Funding Round
Early Stage VC (Series B)
Nov 19, 2025
$106M
raised
Investors
+10 other investors